Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.4 USD
9.40 B USD
68.69 B USD
5.51 B
About ROCHE I
Sector
Industry
CEO
Thomas Schinecker
Website
Headquarters
Basel
Founded
1896
FIGI
BBG00JRY9DR7
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Roche vs. Novo Nordisk: Who will suffer the Weight Loss?Roche (ticker: ROG.SW) is losing ground on the stock due to the side effects of its new weight loss pill, CT-996, which is still in the testing phase. After a rally that boosted its shares 40% between May and September, the Swiss drugmaker has seen an 11% drop in its shares in September alone, inclu
Roche Analysis 6/26DISCLOSURE: as of 6/26 I have no open position in SIX:RO
Roche is a Swiss based pharmaceutical conglomerate with a diverse range of operations and brands. The company has a long history of profitability and high returns on investment.
Management Effectiveness: Roche has been around since 1896
Roche: Ready for 120% Growth?We're trying something with Roche here, where we think that we are currently in Wave (5), having recently completed Wave (4). This assessment is better visualized on the daily chart. Hence, we should maintain the 61.8% level for this Wave 4. Anything below would statistically be too low, while above
Hold it like a rock - Roche, what an opportunity.Hi, 1PERCENT here.
Roche Holding, a Swiss multinational biopharma company. It is like the Apple of biopharma.
There were only 3 pull backs greater than 30% in the history of the stock.
2002 ~ 2003: -45.33%
2006 ~ 2011: -52.40%
2014 ~ 2018: -30.24%
2022 ~ present: -44.89%
It is at the support z
Roche HoldingsThis is one of those companies you can't afford not to look into. Roche is one of the world's largest biotech companies and a global leader in pharmaceuticals and diagnostics. This leading position translates to strong market share, revenue, and profitability. The company operates across various seg
Long Term Weekly Trend holds for nowTrend started in 2012 held during the week. If the price accumulates at the current level and we breakout to the upside, I will watch the marked zones of interest and see how the price reacts.
If we breakout to the down side, I will look for interesting price levels and keep an eye on the trend est
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
CHGCY5317644
Roche Holdings, Inc. 2.607% 13-DEC-2051Yield to maturity
7.23%
Maturity date
Dec 13, 2051
CHGCY4184535
Roche Holdings, Inc. 4.0% 28-NOV-2044Yield to maturity
6.18%
Maturity date
Nov 28, 2044
CHGCY5766486
Roche Holdings, Inc. 5.218% 08-MAR-2054Yield to maturity
6.09%
Maturity date
Mar 8, 2054
CHGCY3666852
Genentech, Inc. 5.25% 15-JUL-2035Yield to maturity
5.48%
Maturity date
Jul 15, 2035
CHGCY5766485
Roche Holdings, Inc. 5.218% 08-MAR-2054Yield to maturity
5.36%
Maturity date
Mar 8, 2054
CHGCY5766483
Roche Holdings, Inc. 4.985% 08-MAR-2034Yield to maturity
5.19%
Maturity date
Mar 8, 2034
CHGCY5698672
Roche Holdings, Inc. FRN 13-NOV-2026Yield to maturity
5.17%
Maturity date
Nov 13, 2026
CHGCY5317198
Roche Holdings, Inc. 2.076% 13-DEC-2031Yield to maturity
5.10%
Maturity date
Dec 13, 2031
CHGCY5766481
Roche Holdings, Inc. 4.909% 08-MAR-2031Yield to maturity
5.09%
Maturity date
Mar 8, 2031
CHGCY5766484
Roche Holdings, Inc. 4.985% 08-MAR-2034Yield to maturity
5.08%
Maturity date
Mar 8, 2034
CHGCY4391962
Roche Holdings, Inc. 7.0% 01-MAR-2039Yield to maturity
5.02%
Maturity date
Mar 1, 2039
See all 0TDF bonds
Curated watchlists where 0TDF is featured.